table of content
1 Study Coverage
1.1 Passive Transdermal Drug Delivery Product Introduction
1.2 Global Passive Transdermal Drug Delivery Outlook 2017 VS 2022 VS 2028
1.2.1 Global Passive Transdermal Drug Delivery Sales in US$ Million for the Year 2017-2028
1.2.2 Global Passive Transdermal Drug Delivery Sales in Volume for the Year 2017-2028
1.3 United States Passive Transdermal Drug Delivery Outlook 2017 VS 2022 VS 2028
1.3.1 United States Passive Transdermal Drug Delivery Sales in US$ Million for the Year 2017-2028
1.3.2 United States Passive Transdermal Drug Delivery Sales in Volume for the Year 2017-2028
1.4 Passive Transdermal Drug Delivery Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Passive Transdermal Drug Delivery in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Passive Transdermal Drug Delivery Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Passive Transdermal Drug Delivery Market Dynamics
1.5.1 Passive Transdermal Drug Delivery Industry Trends
1.5.2 Passive Transdermal Drug Delivery Market Drivers
1.5.3 Passive Transdermal Drug Delivery Market Challenges
1.5.4 Passive Transdermal Drug Delivery Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Passive Transdermal Drug Delivery Market Segment by Type
2.1.1 Microfluidics
2.1.2 Smart Pill Technology (SPT)
2.2 Global Passive Transdermal Drug Delivery Market Size by Type
2.2.1 Global Passive Transdermal Drug Delivery Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Passive Transdermal Drug Delivery Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Passive Transdermal Drug Delivery Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Passive Transdermal Drug Delivery Market Size by Type
2.3.1 United States Passive Transdermal Drug Delivery Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Passive Transdermal Drug Delivery Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Passive Transdermal Drug Delivery Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Passive Transdermal Drug Delivery Market Segment by Application
3.1.1 Clinic
3.1.2 Hospital
3.1.3 Others
3.2 Global Passive Transdermal Drug Delivery Market Size by Application
3.2.1 Global Passive Transdermal Drug Delivery Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Passive Transdermal Drug Delivery Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Passive Transdermal Drug Delivery Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Passive Transdermal Drug Delivery Market Size by Application
3.3.1 United States Passive Transdermal Drug Delivery Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Passive Transdermal Drug Delivery Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Passive Transdermal Drug Delivery Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Passive Transdermal Drug Delivery Competitor Landscape by Company
4.1 Global Passive Transdermal Drug Delivery Market Size by Company
4.1.1 Top Global Passive Transdermal Drug Delivery Manufacturers Ranked by Revenue (2021)
4.1.2 Global Passive Transdermal Drug Delivery Revenue by Manufacturer (2017-2022)
4.1.3 Global Passive Transdermal Drug Delivery Sales by Manufacturer (2017-2022)
4.1.4 Global Passive Transdermal Drug Delivery Price by Manufacturer (2017-2022)
4.2 Global Passive Transdermal Drug Delivery Concentration Ratio (CR)
4.2.1 Passive Transdermal Drug Delivery Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Passive Transdermal Drug Delivery in 2021
4.2.3 Global Passive Transdermal Drug Delivery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Passive Transdermal Drug Delivery Manufacturing Base Distribution, Product Type
4.3.1 Global Passive Transdermal Drug Delivery Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Passive Transdermal Drug Delivery Product Type
4.3.3 Date of International Manufacturers Enter into Passive Transdermal Drug Delivery Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Passive Transdermal Drug Delivery Market Size by Company
4.5.1 Top Passive Transdermal Drug Delivery Players in United States, Ranked by Revenue (2021)
4.5.2 United States Passive Transdermal Drug Delivery Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Passive Transdermal Drug Delivery Sales by Players (2020, 2021 & 2022)
5 Global Passive Transdermal Drug Delivery Market Size by Region
5.1 Global Passive Transdermal Drug Delivery Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Passive Transdermal Drug Delivery Market Size in Volume by Region (2017-2028)
5.2.1 Global Passive Transdermal Drug Delivery Sales in Volume by Region: 2017-2022
5.2.2 Global Passive Transdermal Drug Delivery Sales in Volume Forecast by Region (2023-2028)
5.3 Global Passive Transdermal Drug Delivery Market Size in Value by Region (2017-2028)
5.3.1 Global Passive Transdermal Drug Delivery Sales in Value by Region: 2017-2022
5.3.2 Global Passive Transdermal Drug Delivery Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Passive Transdermal Drug Delivery Market Size YoY Growth 2017-2028
6.1.2 North America Passive Transdermal Drug Delivery Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Passive Transdermal Drug Delivery Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Passive Transdermal Drug Delivery Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Passive Transdermal Drug Delivery Market Size YoY Growth 2017-2028
6.3.2 Europe Passive Transdermal Drug Delivery Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Passive Transdermal Drug Delivery Market Size YoY Growth 2017-2028
6.4.2 Latin America Passive Transdermal Drug Delivery Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Passive Transdermal Drug Delivery Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Passive Transdermal Drug Delivery Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 3M
7.1.1 3M Corporation Information
7.1.2 3M Description and Business Overview
7.1.3 3M Passive Transdermal Drug Delivery Sales, Revenue and Gross Margin (2017-2022)
7.1.4 3M Passive Transdermal Drug Delivery Products Offered
7.1.5 3M Recent Development
7.2 Actavis, Inc.
7.2.1 Actavis, Inc. Corporation Information
7.2.2 Actavis, Inc. Description and Business Overview
7.2.3 Actavis, Inc. Passive Transdermal Drug Delivery Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Actavis, Inc. Passive Transdermal Drug Delivery Products Offered
7.2.5 Actavis, Inc. Recent Development
7.3 Bayer AG
7.3.1 Bayer AG Corporation Information
7.3.2 Bayer AG Description and Business Overview
7.3.3 Bayer AG Passive Transdermal Drug Delivery Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Bayer AG Passive Transdermal Drug Delivery Products Offered
7.3.5 Bayer AG Recent Development
7.4 Boehringer Ingelheim GmbH
7.4.1 Boehringer Ingelheim GmbH Corporation Information
7.4.2 Boehringer Ingelheim GmbH Description and Business Overview
7.4.3 Boehringer Ingelheim GmbH Passive Transdermal Drug Delivery Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Boehringer Ingelheim GmbH Passive Transdermal Drug Delivery Products Offered
7.4.5 Boehringer Ingelheim GmbH Recent Development
7.5 Corium International, Inc.
7.5.1 Corium International, Inc. Corporation Information
7.5.2 Corium International, Inc. Description and Business Overview
7.5.3 Corium International, Inc. Passive Transdermal Drug Delivery Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Corium International, Inc. Passive Transdermal Drug Delivery Products Offered
7.5.5 Corium International, Inc. Recent Development
7.6 Echo Therapeutics, Inc.
7.6.1 Echo Therapeutics, Inc. Corporation Information
7.6.2 Echo Therapeutics, Inc. Description and Business Overview
7.6.3 Echo Therapeutics, Inc. Passive Transdermal Drug Delivery Sales, Revenue and Gross Margin (2017-2022)
7.6.4 Echo Therapeutics, Inc. Passive Transdermal Drug Delivery Products Offered
7.6.5 Echo Therapeutics, Inc. Recent Development
7.7 GlaxoSmithKline plc
7.7.1 GlaxoSmithKline plc Corporation Information
7.7.2 GlaxoSmithKline plc Description and Business Overview
7.7.3 GlaxoSmithKline plc Passive Transdermal Drug Delivery Sales, Revenue and Gross Margin (2017-2022)
7.7.4 GlaxoSmithKline plc Passive Transdermal Drug Delivery Products Offered
7.7.5 GlaxoSmithKline plc Recent Development
7.8 Johnson & Johnson (Janssen Pharmaceuticals Inc.)
7.8.1 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Corporation Information
7.8.2 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Description and Business Overview
7.8.3 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Passive Transdermal Drug Delivery Sales, Revenue and Gross Margin (2017-2022)
7.8.4 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Passive Transdermal Drug Delivery Products Offered
7.8.5 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Recent Development
7.9 Mylan N.V.
7.9.1 Mylan N.V. Corporation Information
7.9.2 Mylan N.V. Description and Business Overview
7.9.3 Mylan N.V. Passive Transdermal Drug Delivery Sales, Revenue and Gross Margin (2017-2022)
7.9.4 Mylan N.V. Passive Transdermal Drug Delivery Products Offered
7.9.5 Mylan N.V. Recent Development
7.10 Novartis AG
7.10.1 Novartis AG Corporation Information
7.10.2 Novartis AG Description and Business Overview
7.10.3 Novartis AG Passive Transdermal Drug Delivery Sales, Revenue and Gross Margin (2017-2022)
7.10.4 Novartis AG Passive Transdermal Drug Delivery Products Offered
7.10.5 Novartis AG Recent Development
7.11 Noven Pharmaceuticals, Inc.
7.11.1 Noven Pharmaceuticals, Inc. Corporation Information
7.11.2 Noven Pharmaceuticals, Inc. Description and Business Overview
7.11.3 Noven Pharmaceuticals, Inc. Passive Transdermal Drug Delivery Sales, Revenue and Gross Margin (2017-2022)
7.11.4 Noven Pharmaceuticals, Inc. Passive Transdermal Drug Delivery Products Offered
7.11.5 Noven Pharmaceuticals, Inc. Recent Development
7.12 Transdermal Corp.
7.12.1 Transdermal Corp. Corporation Information
7.12.2 Transdermal Corp. Description and Business Overview
7.12.3 Transdermal Corp. Passive Transdermal Drug Delivery Sales, Revenue and Gross Margin (2017-2022)
7.12.4 Transdermal Corp. Products Offered
7.12.5 Transdermal Corp. Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Passive Transdermal Drug Delivery Industry Chain Analysis
8.2 Passive Transdermal Drug Delivery Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Passive Transdermal Drug Delivery Distributors
8.3 Passive Transdermal Drug Delivery Production Mode & Process
8.4 Passive Transdermal Drug Delivery Sales and Marketing
8.4.1 Passive Transdermal Drug Delivery Sales Channels
8.4.2 Passive Transdermal Drug Delivery Distributors
8.5 Passive Transdermal Drug Delivery Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
